Searched for
WEIGHT LOSS GLENMARK
Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...09 Apr, 2026, 02.52 PM IST- GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy genericsIndian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and...27 Mar, 2026, 02.22 PM IST
- Centre steps up oversight on GLP-1 drugs amid concerns over 'improper' practicesIndia's drug regulator is increasing oversight of GLP-1 weight loss drugs. Inspections across 49 entities revealed violations like unauthor...25 Mar, 2026, 12.16 AM IST
- Rs 12,000 crore magic pill race begins to shrink India's pot bellies. Which pharma stocks will win GLP-1 war?India's GLP-1 market is set for a massive boom. Following patent expiry, generic versions of semaglutide are launching at significantly low...24 Mar, 2026, 11.14 AM IST
- Indian drugmakers flood market with cheaper versions of Novo's Ozempic, WegovyIndian drugmakers have launched affordable generic versions of popular diabetes and weight-loss drugs. This move significantly reduces trea...23 Mar, 2026, 12.54 PM IST
- GLP-1 rush: Pharma, food firms eye tie-ups for weight-loss boomAffordable weight-loss jabs are here. Drugmakers and food companies are partnering. They will offer special nutrition products. These are f...23 Mar, 2026, 10.06 AM IST
- Alkem Laboratories launches semaglutide in India at Rs 450 per week, eyes booming weight-loss marketAlkem Laboratories has launched a new semaglutide injection in India. This drug targets the growing diabetes and weight loss market. It is ...21 Mar, 2026, 05.07 PM IST
- Natco, Eris Life to launch slimming shots in both Vial and Pen formatsNatco Pharma and Eris Lifesciences are launching generic semaglutide weight-loss injections. The companies are introducing both vial and pe...21 Mar, 2026, 09.35 AM IST
- Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahead?Pharma stocks rose up to 4% as Novo Nordisk’s semaglutide patent nears expiry, raising expectations of cheaper generics in India. Strong gr...20 Mar, 2026, 12.40 PM IST
- Glenmark set to join peers in 'Semaglutide' pushGlenmark Pharmaceuticals is set to launch affordable versions of the popular anti-diabetes and obesity drug semaglutide. This move escalate...02 Mar, 2026, 12.21 AM IST
- Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Co...06 Jul, 2024, 11.12 AM IST
- India to make drugs for diabetes, obesity under PLI by 2026, says reportIndia plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a govern...28 Jun, 2024, 04.23 PM IST
- Ozempic frenzy lures rich Indians to brave the gray marketPeople are going to great lengths to obtain popular weight-loss drugs. They are stashing injectables in their carry-on luggage, buying coun...19 Jun, 2024, 08.25 AM IST
- Pharma may see a price war in good news for diabeticsGlenmark launches a drug at almost half the price of those offered by rivals.01 May, 2019, 07.09 AM IST
- Glenmark Pharma launches anti-diabetes drug Remogliflozin in IndiaGlenmark said it will commercialise Remogliflozin in India under the brand names 'Remo' and 'Remozen'.30 Apr, 2019, 12.20 PM IST
- Market Now: Nifty Pharma in green; Dr Reddy's Labs zooms nearly 8%The Nifty Pharma index was trading 2.41 per cent up at 9,073 around 9.45 am (IST).01 Sep, 2017, 10.26 AM IST
- Brokers' call: ITC, Infosys, pharmaITC’s cigarette business has delivered consistent high teens profit growth over the past six years, despite rising taxes.09 Jan, 2013, 04.00 AM IST
Load More
